Johnson & Johnson in Talks With India for Clinical Study Of Single-Dose Covid-19 Vaccine

The J&J vaccine Phase 3 data shows it is 85% effective in preventing severe disease and 66% to 72% effective in preventing 'moderate to severe' COVID-19 infection.

from Top India News- News18.com https://ift.tt/3dPNPlo